US Stock MarketDetailed Quotes

HRMY Harmony Biosciences

Watchlist
  • 38.980
  • -0.095-0.24%
Close Feb 14 16:00 ET
  • 38.980
  • 0.0000.00%
Post 16:35 ET
2.22BMarket Cap18.47P/E (TTM)

Harmony Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.08%186.04M
28.76%172.81M
29.79%154.62M
32.93%582.02M
31.26%168.41M
36.74%160.27M
25.40%134.22M
39.63%119.13M
43.35%437.86M
40.67%128.31M
Operating revenue
16.08%186.04M
28.76%172.81M
29.79%154.62M
32.93%582.02M
31.26%168.41M
36.74%160.27M
25.40%134.22M
39.63%119.13M
43.35%437.86M
40.67%128.31M
Cost of revenue
32.46%42.78M
28.53%32.14M
32.26%27.48M
45.23%121.24M
60.51%43.15M
40.67%32.3M
32.17%25.01M
41.21%20.78M
50.37%83.48M
50.90%26.89M
Gross profit
11.95%143.26M
28.81%140.67M
29.27%127.13M
30.03%460.79M
23.50%125.26M
35.78%127.97M
23.95%109.21M
39.31%98.35M
41.79%354.37M
38.19%101.42M
Operating expense
28.50%81.55M
91.50%119.31M
29.65%75.1M
14.76%268.76M
58.08%85.06M
-22.93%63.46M
13.30%62.31M
34.58%57.92M
44.21%234.19M
20.21%53.81M
Selling and administrative expenses
22.19%56.16M
17.73%55.73M
18.54%52.91M
18.00%192.69M
25.25%54.76M
9.97%45.96M
11.85%47.34M
25.86%44.63M
23.69%163.3M
17.16%43.72M
-Selling and marketing expense
17.76%27.58M
16.22%28.51M
20.65%27.23M
22.85%97.4M
27.57%26.89M
14.42%23.42M
21.67%24.53M
28.37%22.57M
16.39%79.29M
10.29%21.08M
-General and administrative expense
26.79%28.59M
19.36%27.22M
16.38%25.68M
13.42%95.29M
23.09%27.87M
5.70%22.55M
2.91%22.81M
23.39%22.06M
31.46%84.02M
24.38%22.64M
Research and development costs
45.08%25.39M
324.76%63.58M
66.97%22.19M
7.30%76.06M
200.30%30.31M
-56.84%17.5M
18.16%14.97M
75.36%13.29M
133.43%70.89M
35.44%10.09M
Operating profit
-4.34%61.71M
-54.47%21.36M
28.72%52.03M
59.78%192.03M
-15.58%40.2M
442.05%64.51M
41.63%46.9M
46.69%40.42M
37.31%120.19M
66.30%47.61M
Net non-operating interest income expense
120.10%584K
110.84%301K
95.95%-107K
42.39%-9.03M
80.46%-700K
27.17%-2.91M
29.31%-2.78M
36.56%-2.65M
34.63%-15.67M
14.43%-3.58M
Non-operating interest income
20.12%4.93M
36.69%4.71M
43.49%4.43M
371.21%14.73M
--4.1M
--4.11M
--3.44M
--3.09M
1,295.54%3.13M
----
Non-operating interest expense
-37.99%4.35M
-29.17%4.4M
-20.87%4.54M
26.40%23.76M
-28.51%4.8M
75.74%7.01M
58.34%6.22M
37.47%5.73M
-22.32%18.8M
52.10%6.71M
Other net income (expense)
98.73%-124K
219.35%37K
-7,150.00%-141K
-5,784.62%-9.61M
164.38%193K
-17,548.21%-9.77M
-173.81%-31K
200.00%2K
100.65%169K
135.48%73K
Special income (charges)
--0
----
----
---9.77M
--0
---9.77M
----
----
--0
--0
-Less:Other special charges
----
----
----
--9.77M
--0
--9.77M
----
----
----
----
Other non- operating income (expenses)
-2,380.00%-124K
219.35%37K
-7,150.00%-141K
-5.92%159K
164.38%193K
-108.93%-5K
-173.81%-31K
200.00%2K
956.25%169K
135.48%73K
Income before tax
19.95%62.17M
-50.80%21.69M
37.07%51.79M
65.63%173.4M
-10.01%39.69M
550.58%51.83M
50.85%44.1M
61.56%37.78M
179.70%104.69M
80.20%44.1M
Income tax
20.24%16.08M
3.14%10.1M
62.16%13.45M
158.01%44.54M
396.91%13.08M
116.72%13.37M
71.84%9.8M
336.58%8.3M
-2,812.19%-76.78M
-350.20%-4.41M
Net income
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-28.99%128.85M
-45.15%26.61M
-56.27%38.46M
45.77%34.3M
37.24%29.49M
424.52%181.47M
113.56%48.51M
Net income continuous Operations
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-28.99%128.85M
-45.15%26.61M
-56.27%38.46M
45.77%34.3M
37.24%29.49M
424.52%181.47M
113.56%48.51M
Minority interest income
Net income attributable to the parent company
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-28.99%128.85M
-45.15%26.61M
-56.27%38.46M
45.77%34.3M
37.24%29.49M
424.52%181.47M
113.56%48.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-28.99%128.85M
-45.15%26.61M
-56.27%38.46M
45.77%34.3M
37.24%29.49M
424.52%181.47M
113.56%48.51M
Basic earnings per share
26.56%0.81
-64.91%0.2
38.78%0.68
-29.32%2.17
-43.90%0.46
-56.76%0.64
42.50%0.57
36.11%0.49
411.67%3.07
110.26%0.82
Diluted earnings per share
25.40%0.79
-64.29%0.2
39.58%0.67
-28.28%2.13
-43.04%0.45
-56.25%0.63
43.59%0.56
37.14%0.48
412.07%2.97
107.89%0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 16.08%186.04M28.76%172.81M29.79%154.62M32.93%582.02M31.26%168.41M36.74%160.27M25.40%134.22M39.63%119.13M43.35%437.86M40.67%128.31M
Operating revenue 16.08%186.04M28.76%172.81M29.79%154.62M32.93%582.02M31.26%168.41M36.74%160.27M25.40%134.22M39.63%119.13M43.35%437.86M40.67%128.31M
Cost of revenue 32.46%42.78M28.53%32.14M32.26%27.48M45.23%121.24M60.51%43.15M40.67%32.3M32.17%25.01M41.21%20.78M50.37%83.48M50.90%26.89M
Gross profit 11.95%143.26M28.81%140.67M29.27%127.13M30.03%460.79M23.50%125.26M35.78%127.97M23.95%109.21M39.31%98.35M41.79%354.37M38.19%101.42M
Operating expense 28.50%81.55M91.50%119.31M29.65%75.1M14.76%268.76M58.08%85.06M-22.93%63.46M13.30%62.31M34.58%57.92M44.21%234.19M20.21%53.81M
Selling and administrative expenses 22.19%56.16M17.73%55.73M18.54%52.91M18.00%192.69M25.25%54.76M9.97%45.96M11.85%47.34M25.86%44.63M23.69%163.3M17.16%43.72M
-Selling and marketing expense 17.76%27.58M16.22%28.51M20.65%27.23M22.85%97.4M27.57%26.89M14.42%23.42M21.67%24.53M28.37%22.57M16.39%79.29M10.29%21.08M
-General and administrative expense 26.79%28.59M19.36%27.22M16.38%25.68M13.42%95.29M23.09%27.87M5.70%22.55M2.91%22.81M23.39%22.06M31.46%84.02M24.38%22.64M
Research and development costs 45.08%25.39M324.76%63.58M66.97%22.19M7.30%76.06M200.30%30.31M-56.84%17.5M18.16%14.97M75.36%13.29M133.43%70.89M35.44%10.09M
Operating profit -4.34%61.71M-54.47%21.36M28.72%52.03M59.78%192.03M-15.58%40.2M442.05%64.51M41.63%46.9M46.69%40.42M37.31%120.19M66.30%47.61M
Net non-operating interest income expense 120.10%584K110.84%301K95.95%-107K42.39%-9.03M80.46%-700K27.17%-2.91M29.31%-2.78M36.56%-2.65M34.63%-15.67M14.43%-3.58M
Non-operating interest income 20.12%4.93M36.69%4.71M43.49%4.43M371.21%14.73M--4.1M--4.11M--3.44M--3.09M1,295.54%3.13M----
Non-operating interest expense -37.99%4.35M-29.17%4.4M-20.87%4.54M26.40%23.76M-28.51%4.8M75.74%7.01M58.34%6.22M37.47%5.73M-22.32%18.8M52.10%6.71M
Other net income (expense) 98.73%-124K219.35%37K-7,150.00%-141K-5,784.62%-9.61M164.38%193K-17,548.21%-9.77M-173.81%-31K200.00%2K100.65%169K135.48%73K
Special income (charges) --0-----------9.77M--0---9.77M----------0--0
-Less:Other special charges --------------9.77M--0--9.77M----------------
Other non- operating income (expenses) -2,380.00%-124K219.35%37K-7,150.00%-141K-5.92%159K164.38%193K-108.93%-5K-173.81%-31K200.00%2K956.25%169K135.48%73K
Income before tax 19.95%62.17M-50.80%21.69M37.07%51.79M65.63%173.4M-10.01%39.69M550.58%51.83M50.85%44.1M61.56%37.78M179.70%104.69M80.20%44.1M
Income tax 20.24%16.08M3.14%10.1M62.16%13.45M158.01%44.54M396.91%13.08M116.72%13.37M71.84%9.8M336.58%8.3M-2,812.19%-76.78M-350.20%-4.41M
Net income 19.84%46.09M-66.21%11.59M30.01%38.33M-28.99%128.85M-45.15%26.61M-56.27%38.46M45.77%34.3M37.24%29.49M424.52%181.47M113.56%48.51M
Net income continuous Operations 19.84%46.09M-66.21%11.59M30.01%38.33M-28.99%128.85M-45.15%26.61M-56.27%38.46M45.77%34.3M37.24%29.49M424.52%181.47M113.56%48.51M
Minority interest income
Net income attributable to the parent company 19.84%46.09M-66.21%11.59M30.01%38.33M-28.99%128.85M-45.15%26.61M-56.27%38.46M45.77%34.3M37.24%29.49M424.52%181.47M113.56%48.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.84%46.09M-66.21%11.59M30.01%38.33M-28.99%128.85M-45.15%26.61M-56.27%38.46M45.77%34.3M37.24%29.49M424.52%181.47M113.56%48.51M
Basic earnings per share 26.56%0.81-64.91%0.238.78%0.68-29.32%2.17-43.90%0.46-56.76%0.6442.50%0.5736.11%0.49411.67%3.07110.26%0.82
Diluted earnings per share 25.40%0.79-64.29%0.239.58%0.67-28.28%2.13-43.04%0.45-56.25%0.6343.59%0.5637.14%0.48412.07%2.97107.89%0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call